Autoimmune Disease
![](/cms/asset/0e2bcff9-2240-436d-9469-63f5844285c4/Untitled design (5)-tfocoll-collection-image.jpeg)
Immunotargets and Therapy is pleased to invite you to submit your research to its latest Article Collection on "Autoimmune Disease.”
The Collection, led by Editor-In-Chief Professor Michael Shurin, welcomes relevant Reviews, Original Research and Editorials up until the 31st December 2024. The Collection promises to be a valuable resource for years to come, with articles published alongside some of our finest hot-topic reviews.
While the call is open to receive manuscripts across the broad spectrum of autoimmune diseases, the Editors are particularly interested in manuscripts relating to these key areas:
-
Natural Autoantibodies
-
Autoimmune disorders: New epidemiological data
-
Pathophysiology of autoimmune diseases
-
Novel diagnostic and therapeutic approaches for autoimmune disorders
-
Therapeutic targeting of autoantibodies
-
Clinical utilization of autoantibodies
-
Regulatory immune cells for the treatment of autoimmune diseases
-
Autoantigenomics
-
AI in autoimmunity
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please submit your manuscript on our website, using the promo code ZFWRR for 20% off the advertised article processing charge and to indicate that your manuscript will be considered for the “Autoimmune Diseases” Collection.
Please review the journal scope and author submission instructions prior to submitting a manuscript.
The deadline for submitting manuscripts is 31st December 2024.
Please contact Ashley Ambros with any queries regarding this Article Collection or available APC discounts.
Edited by
Professor Michael R. Schurin(Department of Pathology and Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA)
Michael R. Shurin, MD, PhD is a Professor of Pathology and Immunology at the University of Pittsburgh Medical Center and an associate director of the Division of Clinical Immunopathology. He leads a unique research program focusing on cellular and molecular interactions in the tumor microenvironment supported by NIH and other foundations.